This next-generation automated platform aims to solve the challenges commonly associated with batch production of lipid nanoparticles and liposomes for drug and vaccine development
The semi-automated device uses new-generation TRPS technology, enabling the measurement of complex nanoparticle size, concentration, and charge—with unparalleled precision and accuracy